Search - tctmd.com

Displaying 481 - 500 of 4296

Sort: Relevancy | Date

Presentation TCT 2024

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

Presenter: Ron Waksman

October 28, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Presenter: Amit Vora

October 28, 2024

Presentation TCT 2024

Case: New LBBB After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Post-TAVR Risk-Stratification for Conduction Disturbances

Presenter: Shmuel Chen

October 28, 2024

Presentation TCT 2024

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

Presenter: Jaroslaw Trebacz

October 28, 2024

Presentation TCT 2024

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

Presenter: Amar Krishnaswamy

October 28, 2024

Presentation TCT 2024

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

Presenter: Pradeep Yadav

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

How Do I Plan to Prevent and Manage the Complications of mTEER?

Presenter: Marek Grygier

October 28, 2024

Presentation TCT 2024

The Foldax Polymeric Leaflet TAVR Systems

Presenter: Steven Yakubov

October 28, 2024

Presentation TCT 2024

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

Presenter: Rafael Meneguz-Moreno

October 28, 2024

Presentation TCT 2024

TCT 617: Hospital Dispersion and Patient Outcomes of Transcatheter Mitral Valve Repair

Presenter: Atsuyuki Watanabe

October 28, 2024

Presentation TCT 2024

TCT 1147: Transfemoral Valve in MAC TMVR With a Balloon Expandable Prosthesis and Balloon Assisted Translocation of the Anterior Mitral Valve Leaflet (BATMAN)

Presenter: Vlasis Ninios

October 28, 2024

Presentation TCT 2024

TCT 620: Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-to-Edge Repair

Presenter: Mark Lachmann

October 28, 2024

Presentation TCT 2024

TCT 1483: LAMPOON-Assisted Transcatheter Mitral Valve-in-Valve Replacement

Presenter: Ganesan Nambirajan

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

TCT 338: Clinical and Echocardiographic Predictors of Persistent Mitral Regurgitation Post Transcatheter Aortic Valve Replacement

Presenter: Nawaf Al-Furaih

October 28, 2024

Presentation TCT 2024

The ALLOW?Study:?ALLegra?TAVR Outcomes?in the Real?World

Presenter: Ignacio Cruz Gonzalez

October 28, 2024

Advertisement

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Case: New LBBB After TAVR

Post-TAVR Risk-Stratification for Conduction Disturbances

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

The EARLY TAVR Trial Editorial Commentary

How Do I Plan to Prevent and Manage the Complications of mTEER?

The Foldax Polymeric Leaflet TAVR Systems

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

TCT 617: Hospital Dispersion and Patient Outcomes of Transcatheter Mitral Valve Repair

TCT 1147: Transfemoral Valve in MAC TMVR With a Balloon Expandable Prosthesis and Balloon Assisted Translocation of the Anterior Mitral Valve Leaflet (BATMAN)

TCT 620: Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-to-Edge Repair

TCT 1483: LAMPOON-Assisted Transcatheter Mitral Valve-in-Valve Replacement

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

TCT 338: Clinical and Echocardiographic Predictors of Persistent Mitral Regurgitation Post Transcatheter Aortic Valve Replacement

The ALLOW?Study:?ALLegra?TAVR Outcomes?in the Real?World

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content